reported that, in depression breast cancer mice, Shugan Jianpi formula combined with chemotherapy drug gemcitabine (GEM) effectively repressed the apoptosis of CD8+ T cells and significantly reduced MDSCs to enhance the immune surveillance, thereby preventing the progress of breast cancer (48). This evidence concerns the gene CD8A and breast carcinoma.